Health care stocks were declining premarket Friday, with The Health Care Select Sector SPDR Fund (XLV) 0.4% lower and the iShares Biotechnology ETF (IBB) down 0.9%.
Alignment Healthcare (ALHC) shares were down past 14% after the company announced privately negotiated subscription deals with certain investors to issue $330 million of 4.25% convertible senior unsecured notes due Nov. 15, 2029.
TFF Pharmaceuticals (TFFP) stock was more than 75% lower after its board approved the company's dissolution and liquidation.
Eyenovia (EYEN) shares were down more than 58% after the company said that a phase 3 study evaluating its drug-device combination of low-dose atropine in the company's Optejet dispensing platform for pediatric progressive myopia did not meet its primary endpoint.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。